A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues
|
|
- Beverly Owen
- 5 years ago
- Views:
Transcription
1 A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding normal tissues No. of spots: 1 spot from each cancer case (12 spots) 12 non-neoplastic spots (12 spots) Total spots: 24 Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm Documents: Product specification: layout, summary of tissue spots H&E stained images Detailed pathological information Layout: P T
2 A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues Summary of tissue spots (formalin fixed) For research use only P T
3 A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only QC sheet_lot# Hematoxylin and Eosin staining A1 A2 A3 A4 A5 B1 B2 B3 B4 B5 C1 C2 C3 C4 C5 D1 D2 D3 D4 D5 E1 E2 F1 F2 P T
4 1 A 1 f 49 Breast, right, total mastectomy with SLNB: 1. 1) Size: 2.8x1.9cm 2) Black's nuclear grade: 1 (poorly differentiated) 3) Modified Bloom-Richardson's histological grade: III 4) Intraductal component: 15% 5) Resection margins: Negative 6) Vascular invasion: Present 7) Perineural invasion: Absent 8) Microcalcification: Present in invasive cancer, in associated with benign epithelium, in stroma 9) Immunohistochemistry: ER(+), PR(+), C erb B2 (weak +:2+/3+) 2.Nipple and areola: Free of tumor. 3.Overlying skin: Free of tumor. 4.Underlying fascia: Free of tumor. 5.Lymph node, sentinel(0/4), axillary(0/3), regional(0/2):(0/9): Free of tumor. 2 B 1 f 49 non-neoplastic non-neoplastic from A1 3 A 2 f 66 Breast, left, modified radical mastectomy: 1.Status incisional biopsy with residual invasive ductal 1) Size of the residual tumor: 2x1.8cm 2) Site: LO quadrant 3) Black's nuclear grade: I (poorly differentiated) 4) Modified Bloom-Richardson's histological grade: III 5) Intraductal component: 10% 6) Vascular invasion: Present 7) Perineural invasion: Absent 8) Microcalcification: Present, In invasive cancer, In DCIS, In association with benign epithelium 9) Immunohistochemistry: ER(-), PR(+), C erb B2(-: 0/3+) 2.Nipple and areola: Free of tumor 3.Lymph node, sentinel(2/2), axillary(2/24):(4/26):tumor metastasis in 4 out of 26 nodes 4 B 2 f 66 non-neoplastic non-neoplastic from A2
5 5 A 3 f 45 Breast, left, modified radical mastectomy: 1. 1) Size: 3x2cm 2) Black's nuclear grade: I (poorly differentiated) 3) Modified Bloom-Richardson's histological grade: III 4) EIC:present 5) Resection margins: Negative 6) Vascular invasion: Present 7) Perineural invasion: Absent 8) Microcalcification: Present in invasive cancer and ductal in situ 9) Immunohistochemistry: ER(focal +), PR(-), C erb B2(+:3+/3+) 10)Back ground ductal in situ 1 Nuclear grade: high 2 Histologic grade: high 3 Necrosis: Present (comedo) 4 Architecture type: Cribriform, solid 5 Extent of ductal in situ: about 8x5cm 6 Calcification: Present in ductal in situ 7 Microinvasion: Present 2.Nipple and areola: Free of tumor. 3.Overlying skin: Free of tumor. 4.Underlying fascia: Free of tumor. 5.Lymph node, axillary(2/31):tumor metastasis in 2 out of 31 nodes (with pericapslar tumor spread: largest size of tumor deposit: 3.3x2.5cm) 6 B 3 f 45 non-neoplastic non-neoplastic from A3
6 7 A 4 f 58 Breast, left, modified radical mastectomy: 1. 1) Size: 1.5x1.3cm and 0.5x0.3cm(each separated by 1.5cm) 2) Black's nuclear grade: 1(poorly differentiated) 3) Modified Bloom-Richardson's histological grade: III 4) EIC: Present 5) Vascular invasion: Present 6) Perineural invasion: Absent 7) Microcalcification: Absent 8) Immunohistochemistry: ER(-), PR(-), C erb B2(-: 0/3+) 9) Ductal in situ in the background 1. Nuclear grade: high 2. Histological grade: intermediate 3. Necrosis: absent 4. Architectural types: cribriform, solid 5. Extent of DCIS: 4x3cm 6. Calcification: absent 10) Associated benign changes: Fibrocystic change with florid ductal epithelial hyperplasia. 2.Nipple and areola: Free of tumor. 3.Overlying skin: Free of tumor. 4.Underlying fascia: Free of tumor. 5.Lymph node, axillary(2/35): Tumor metastasis in 2 out of 35 nodes (without pericapsular tumor spread)(size of the largest metastatic tumor: 1.5x1.0mm) 8 B 4 f 58 non-neoplastic non-neoplastic from A4
7 9 A 5 f 50 non-neoplastic Breast, ringht, skin sparing total mastectomy: 1. Size: 3x3x2cm 2. Black's nuclear grade: 1 (poorly differentiated) 4. EIC: Present 6. Vascular invasion: Absent 8. Microcalcification: Present in association with benign epithelium Overlying skin: Free of tumor. Underlying fascia: Free of tumor. Lymph node, axillary(0/3): Free of tumor. Breast, labelled as "subareolar subcutaneous tissue", excision: Free of tumor. Result of immunohistochemical stains: ER(+), PR(+), C erb B2(weak +: 2+/3+) 10 B 5 f 50 non-neoplastic non-neoplastic from A5 11 C 1 f 69 Breast, right, partial mastectomy: 1. Size: 2.2x1.3cm 2. Black's nuclear grade: 1 (poorly differentiated) 3. Modified Bloom-Richardson's histological grade:iii 4. Intraductal component: 10% 6. Vascular invasion: Absent 8. Microcalcification: Present in invasive cancer, in ductal in situ 9. ER(+), PR(+), C erb B2(weak+:2+/3+) Underlying fascia: Free of tumor. Lymph node, sentinel(0/2): Free of tumor. 12 D 1 f 69 non-neoplastic non-neoplastic from C1
8 13 C 2 f 58 Breast, right, modified radical mastectomy: 1. Size: 2.2x1.3cm 2. Black's nuclear grade: I (poorly differentiated) 4. EIC: positive 6. Vascular invasion: Absent 8. Microcalcification: Present in invasive cancer, in associated with benign epithelium, in stroma 9. Immunohistochemistry: ER(-), PR(-), C erb B2(-:0+/3+) 10. Showing histologic changes of adjuvant chemotherapy 11. Associated benign changes: Fibroadenoma. Nipple and areola: Free of tumor. Overlying skin: Free of tumor. Underlying fascia: Free of tumor. Lymph node, axillary(0/7): Free of tumor. 14 D 2 f 58 non-neoplastic non-neoplastic from C2
9 15 C 3 f 59 Breast, left, total mastectomy: 1. Size: 2.3x1.8cm 2. Black's nuclear grade: I (poorly differentiated) 4. EIC: positive 6. Vascular invasion: Absent 7. Perineural invasion: Present 8. Microcalcification: Present in invasive cancer, in ductal in situ, in associated with benign epithelium, in stroma 9. ER(-), PR(-), C erb B2(+:3+/3+) Nipple and areola: Paget's disease. Overlying skin: Free of tumor. Underlying fascia: Free of tumor. Lymph node, sentinel(0/4):free of tumor 16 D 3 f 59 non-neoplastic non-neoplastic from C3
10 17 C 4 f 46 Breast, left, partial mastectomy: 1. Size: 2.2x1.7cm 2. Black's nuclear grade: I (poorly differentiated) 4. EIC: Present Distance to closest (relevant) margin: 2mm Relevant margin is superior 6. Vascular invasion: Present 8. Microcalcification: Present in invasive cancer, in ductal in situ, in associated with benign epithelium, in stroma 9. Immunohistochemistry: ER(-), PR(+), C erb B2(-:0/3+) 10. Ductal in situ in the background 1) Nuclear grade: High 2) Histological grade: High 3) Necrosis: Present (Comedo) 4) Architectural types: Solid 5) Extent of DCIS: 9x6cm 6) Microinvasion: Absent (multifocal) Lymph node, sentinel(0/2): Free of tumor. 18 D 4 f 46 non-neoplastic non-neoplastic from C4
11 19 C 5 f D 5 f 39 non-neoplastic non-neoplastic from C5 Breast, left, partial mastectomy: mixed with mucinous 1. Size: 2.2x1.8cm 2. Black's nuclear grade: I (poorly differentiated) 4. Intraductal component: No 6. Vascular invasion: Absent 8. Microcalcification: Present in invasive cancer, in associated with benign epithelium 9. Immunohistochemistry: ER(+), PR(+), C erb B2(-:0/3+) Note: About 60-70% of the tumor consists of mucinous and this case cannot be categories as pure mucinous. E 1 f 39 Breast, left(upper outer), partial mastectomy: mixed with mucinous 1. Size: 2x1cm 2. Black's nuclear grade: II (moderately differentiated) 4. Intraductal component: No 6. Vascular invasion: Present 8. Microcalcification: Absent 9. Immunohistochemistry: ER(+), PR(+), C erb B2(-:1+/3+), Synaptophysin (focal +), chromogranin(-), NSE(-) Lymph node, sentinel (1/1), axillary (4/18): (5/19): Tumor metastasis in 5 out of 19 nodes. (size of the largest metastatic tumor: 1.8x1.5 cm) with perinodal tumor spread Note: About 40-50% of the tumor consists of mucinous. 22 F 1 f 39 non-neoplastic non-neoplastic from E1
12 23 E 2 f 46 Breast, left, partial mastectomy: 1. Size: 1.4x1.3cm 2. Black's nuclear grade: 1 (poorly differentiated) 4. Intraductal component: < 5% 5. With areas of invasive micropapillary 6. Vascular invasion: Present 8. Microcalcification: Absent 9. Immunohistochemistry: ER(+), PR(+), C erb B2(-:0/3+ ) Lymph node, sentinel (1/4), axillary (0/4): (1/8): Tumor metastasis in one out of 8 nodes with focal perinodal tumor spread. (size of the metastatic tumor: 2x1mm) 24 F 2 f 46 non-neoplastic non-neoplastic from F1
A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues
A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding
More informationACRIN 6666 Therapeutic Surgery Form
S1 ACRIN 6666 Therapeutic Surgery Form 6666 Instructions: Complete a separate S1 form for each separate area of each breast excised with the intent to treat a cancer (e.g. each lumpectomy or mastectomy).
More informationBreast pathology. 2nd Department of Pathology Semmelweis University
Breast pathology 2nd Department of Pathology Semmelweis University Breast pathology - Summary - Benign lesions - Acute mastitis - Plasma cell mastitis / duct ectasia - Fat necrosis - Fibrocystic change/
More information04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA
Intraductal Papillary Neoplasms Of Breast Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head The University of Texas MD Anderson Cancer Center 25 th Annual Seminar in Pathology Pittsburgh,
More informationCase Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.
Case Scenario 1 1/3/11 A 57 year old white female presents for her annual mammogram and is found to have a suspicious area of calcification, spread out over at least 4 centimeters. She is scheduled to
More informationCase Scenario 1 History and Physical 3/15/13 Imaging Pathology
Case Scenario 1 History and Physical 3/15/13 The patient is an 84 year old white female who presented with an abnormal mammogram. The patient has a five year history of refractory anemia with ringed sideroblasts
More informationBreast Pathology. Breast Development
Breast Pathology Lecturer: Hanina Hibshoosh, M.D. Reading: Kumar, Cotran, Robbins, Basic Pathology, 6th Edition, pages 623-635 Breast Development 5th week - thickening of the epidermis - milk line 5th
More informationBREAST PATHOLOGY. Fibrocystic Changes
BREAST PATHOLOGY Lesions of the breast are very common, and they present as palpable, sometimes painful, nodules or masses. Most of these lesions are benign. Breast cancer is the 2 nd most common cause
More informationImage guided core biopsies:
Recommendations on the Surgical, Radiologic and Pathologic Approaches to Breast Disease: Using best practices based on multidisciplinary methodologies developed through the Allina Breast Committee. Image
More information(formalin fixed) 6 non-neoplastic spots (6 spots) Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm
CBA729-Test slide, Head and neck cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 6 Tissue type: Test slide, Head and neck cancer tissues No. of spots: 6 spots from each
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More informationCase #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).
SOLID TUMORS WORKSHOP Cases for review Prostate Cancer Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ). January 2009 PSA 4.4, 20% free; August 2009 PSA 5.2; Sept 2009
More informationQ&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast
Collecting Cancer Data Breast NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationHow to Use MRI Following Neoadjuvant Chemotherapy (NAC) in Locally Advanced Breast Cancer
Global Breast Cancer Conference 2016 & 5 th International Breast Cancer Symposium April 29 th 2016, 09:40-10:50 How to Use MRI Following Neoadjuvant Chemotherapy (NAC) in Locally Advanced Breast Cancer
More informationDuctal Carcinoma-in-Situ: New Concepts and Controversies
Ductal Carcinoma-in-Situ: New Concepts and Controversies James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS Case Presentation
More informationProtocol for the Examination of Biopsy Specimens From Patients With Invasive Carcinoma of the Breast
Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast Version: BreastInvasive 1.0.0.0 Protocol Posting Date: February 2019 Accreditation Requirements The use of
More informationRecurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction
Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction Aldona J. Spiegel, M.D., and Charles E. Butler, M.D. Houston, Texas Skin-sparing
More informationA215- Urinary bladder cancer tissues
A215- Urinary bladder cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Urinary bladder cancer tissues No. of spots: 2 spots from each cancer case (90
More informationNEUROENDOCRINE DIFFERENTIATED BREAST CARCINOMA
+ NEUROENDOCRINE DIFFERENTIATED BREAST CARCINOMA + INTRODUCTION + NEUROENDOCRINE FEATURES IN BREAST CARCINOMA Incidence of 2-5% Seen in various histopathological types of breast carcinoma Seen in both
More informationDiagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Pathology. AGO e. V. in der DGGG e.v. sowie in der DKG e.v.
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Pathology Pathology Versions 2004 2017: Blohmer / Costa / Fehm / Friedrichs / Huober / Kreipe / Lück / Schneeweis / Sinn /
More informationProtocol for the Examination of Specimens from Patients with Invasive Carcinoma of the Breast
Protocol for the Examination of Specimens from Patients with Invasive Carcinoma of the Breast Protocol applies to all invasive carcinomas of the breast, including ductal carcinoma in situ (DCIS) with microinvasion.
More informationResection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland
Resection Margins in Breast Conserving Surgery Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland Breast Conserving Surgery 1 Probably one of the most important innovation in cancer surgery
More informationCase study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research
NCCN/JCCNB Seminar in Japan April 15, 2012 Case study 1 Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research Present illness: A 50y.o.premenopausal
More informationCollecting Cancer Data: Breast. Prizes! Collecting Cancer Data: Breast 8/4/ NAACCR Webinar Series 1. NAACCR Webinar Series
Collecting Cancer Data: Breast NAACCR 2008 2009 Webinar Series Prizes! Question of the Month! The participant that submits the best question of the session will receive a fbl fabulous Pi Prize! Shannon
More informationSurgical Pathology Issues of Practical Importance
Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast
More informationTable of contents. Page 2 of 40
Page 1 of 40 Table of contents Introduction... 4 1. Background Information... 6 1a: Referral source for the New Zealand episodes... 6 1b. Invasive and DCIS episodes by referral source... 7 1d. Age of the
More informationCase Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.
Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Background: 46 year old married premenopausal female with dense breasts has noticed
More informationKidney Case 1 SURGICAL PATHOLOGY REPORT
Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which
More informationRecent advances in breast cancers
Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response
More informationProtocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast
Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast Version: Protocol Posting Date: June 2017 Includes ptnm requirements from the 8 th Edition, AJCC Staging Manual
More informationProtocol for the Examination of Resection Specimens From Patients With Invasive Carcinoma of the Breast
Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast Version: Breast Invasive 4.2.0.0 Protocol Posting Date: February 2019 CAP Laboratory Accreditation Program
More informationNAME/ AGE/57 SEX/Female AREA/Australia Visit 1: 5/8/2011. Right Breast Cancer Infiltrating Ductal Carcinoma, no specific type, Grade 1 to 2.
Breast Cancer-CAM Rx NAME/ AGE/57 SEX/Female AREA/Australia Visit 1: 5/8/2011 Case History Discussion Right Breast Cancer Infiltrating Ductal Carcinoma, no specific type, Grade 1 to 2. Patient visited
More informationBreast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined
Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases
More informationRSNA, /radiol Appendix E1. Methods
RSNA, 2016 10.1148/radiol.2016151097 Appendix E1 Methods US and Near-infrared Data Acquisition Four optical wavelengths (740 nm, 780 nm, 808 nm, and 830 nm) were used to sequentially deliver the light
More informationBreast Cancer. Saima Saeed MD
Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast
More informationInvasive Papillary Breast Carcinoma
410 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the
More informationCase Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.
Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Background: 46 year old married premenopausal female with dense breasts has noticed
More informationDefinition of Synoptic Reporting
Definition of Synoptic Reporting The CAP has developed this list of specific features that define synoptic reporting formatting: 1. All required cancer data from an applicable cancer protocol that are
More informationDuctal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA
Ductal Carcinoma in Situ Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Definition of DCIS WHO 2012 A neoplastic proliferation
More informationTake Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules
Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Case 1 72 year old white female presents with a nodular thyroid. This was biopsied in
More informationPapillary Lesions of the Breast: WHO Update
Papillary Lesions of the Breast: WHO Update Stuart J. Schnitt, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Papillary Lesions of the Breast
More informationLesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node
Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node Oil Cyst Mass, Intermediate Concern Microlobulated Margins Obscured Margins Mass, Favoring Malignant Indistinct
More informationCLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES
Papillomas. Papillomas are composed of multiple branching fibrovascular cores, each having a connective tissue axis lined by luminal and myoepithelial cells ( Fig. 23-11 ). Growth occurs within a dilated
More informationContents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ
Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5
More informationPRINCIPLES OF BREAST SURGERY & COMPLICATIONS
PRINCIPLES OF BREAST SURGERY & COMPLICATIONS Adam Cichowitz The Royal Melbourne Hospital ANATOMY Lies in subcutaneous tissue Base: midline to midaxillary line, 2nd to 6th rib Overlies pec major, serratus
More informationBREAST PATHOLOGY MCQS
BREAST PATHOLOGY MCQS 1) :The most important factor in breast enlargement during pregnancy is A. stromal edema B. secretion of chorionic gonadotropin C. glandular hyperplasia D. proliferation of stroma
More informationHandout for Dr Allison s Lectures on Grossing Breast Specimens:
Handout for Dr Allison s Lectures on Grossing Breast Specimens: Dr. Kimberly H. Allison Director of Breast Pathology and Breast Pathology Fellowship Director of Residency Training in Pathology Stanford
More informationPromise of a beautiful day
Promise of a beautiful day Ductal carcinoma in Situ Lobular Carcinoma in Situ Natural History Manosmed Tartous Oct 2009 Gérard ABADJIAN MD Pathology Department Hôtel-Dieu de France. Associate Professor
More informationBREAST PATHOLOGY GROSSING GUIDELINES
THINGS TO CONSIDER: A. Please review ALL imaging and previous biopsies PRIOR to grossing any breast case. a. It may be helpful to draw out your own guide to assist when grossing B. Faxitron your breast
More informationOverview of AJCC 8 th Staging in Pathologic Aspects
Overview of AJCC 8 th Staging in Pathologic Aspects Jee Yeon KIM, M.D.,Ph.D. Department of Pathology, Pusan National University, College of Medicine, Pusan National University Yangsan Hospital, KOREA Major
More informationImmunohistochemical studies (ER & Ki-67) in Proliferative breast lesions adjacent to malignancy
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 13, Issue 3 Ver. IV. (Mar. 2014), PP 84-89 Immunohistochemical studies (ER & Ki-67) in Proliferative
More informationA218 : Esophagus cancer tissues. (formalin fixed)
(formalin fixed) For research use only Specifications: No. of cases: 40 Tissue type: Esophagus cancer tissues No. of spots: 2 spots from each cancer case (80 spots) 4 non-neoplastic spots (4 spots) Total
More informationCollaborative approach to national implementation of Standardization Pathology Reporting. June 2014 Avril Kwiatkowski
Collaborative approach to national implementation of Standardization Pathology Reporting June 2014 Avril Kwiatkowski Overview 1. Partnership role and mandate 2. Clinical value and impact of Synoptic Reporting
More informationYour Guide to the Breast Cancer Pathology. Report. Key Questions. Here are important questions to be sure you understand, with your doctor s help:
Your Guide to the Breast Cancer Pathology Report Key Questions Here are important questions to be sure you understand, with your doctor s help: Your Guide to the Breast Cancer Pathology Report 1. Is this
More informationDiseases of the breast (1 of 2)
Diseases of the breast (1 of 2) Introduction A histology introduction Normal ducts and lobules of the breast are lined by two layers of cells a layer of luminal cells overlying a second layer of myoepithelial
More informationPathology Report Patient Companion Guide
Pathology Report Patient Companion Guide Breast Cancer - Understanding Your Pathology Report Pathology Reports can be overwhelming. They contain scientific terms that are unfamiliar and might be a bit
More informationMammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand
Mammographic imaging of nonpalpable breast lesions Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand Introduction Contents Mammographic signs of nonpalpable breast cancer
More informationCURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY
CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY JULY, 2003 The following is a conceptual curriculum and set of guidelines for Pathology Residents on the Breast
More informationEvaluation of Breast Specimens Removed by Needle Localization Technique
Evaluation of Breast Specimens Removed by Needle Localization Technique Specimen Handling: The breast specimen when received should be measured and grossly inspected for any orientation designated by the
More informationBREAST SURGERY PROGRESS TEST Name:
General Surgery Residency Program Excellent surgeons BREAST SURGERY PROGRESS TEST Name: Choose the BEST answer for the following questions. 1. All of the following factors are associated with an increased
More informationCytyc Corporation - Case Presentation Archive - March 2002
FirstCyte Ductal Lavage History: 68 Year Old Female Gail Index: Unknown Clinical History: Negative Mammogram in 1995 6 yrs. later presents with bloody nipple discharge Subsequent suspicious mammogram Suspicious
More informationUpdate on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.
1 Our speaker for this program is Dr. Anja Roden, an associate professor of Laboratory Medicine and Pathology at Mayo Clinic as well as consultant in the Anatomic Pathology Laboratory and co-director of
More informationAmerican Journal of Cancer Case Reports. Invasive Papillary Carcinoma of Male Breast: A Rare Case Report
American Journal of Cancer Case Reports http://ivyunion.org/index.php/ajccr SantraAetal. American Journal of Cancer Case Reports 2014, 3:56-61 Page 1 of 6 Vol 3 Article ID 20140617, 6 pages Case Report
More informationInvasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature
Sun et al. BMC Cancer (2019) 19:31 https://doi.org/10.1186/s12885-018-5260-2 CASE REPORT Open Access Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report
More informationCPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.
CPC 4 Breast Cancer Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast. 1. What are the most likely diagnoses of this lump? Fibroadenoma
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationClinical Trials of Proton Therapy for Breast Cancer. Andrew L. Chang, MD 張維安 Study Chair
Clinical Trials of Proton Therapy for Breast Cancer Andrew L. Chang, MD 張維安 Study Chair AndrewLChangMD@gmail.com Disclosure Proton Center Development Corporation Scripps San Diego Proton Therapy Center
More informationLYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR
BREAST LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR HISTOLOGY LOBE: (10 in whole breast) LOBULE: (many per lobe) ACINUS/I, aka ALVEOLUS/I: (many per lobule) DUCT(S): INTRA- or
More informationImaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since
Imaging in breast cancer Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since A mammogram report is a key component of the breast cancer diagnostic process. A mammogram
More informationCase Report Synchronous Bilateral Solid Papillary Carcinomas of the Breast
Case Reports in Surgery Volume 2013, Article ID 812129, 4 pages http://dx.doi.org/10.1155/2013/812129 Case Report Synchronous Bilateral Solid Papillary Carcinomas of the Breast Noriko Yoshimura, 1 Shigeru
More informationVULVAR CARCINOMA. Page 1 of 5
VULVAR CARCINOMA EXAMPLE OF A VULVAR CARCINOMA USING PROPOSED TEMPLATE Case: Invasive squamous cell carcinoma arising in D-VIN Tumor in left labia major Left partial vaginectomy and sentinel lymph node
More informationBreast Surgery: Yesterday, Today and Tomorrow
Breast Surgery: Yesterday, Today and Tomorrow Baptist Hospital Gladys L. Giron, MD, FACS October 11,2014 Homestead Hospital Baptist Children s Hospital Doctors Hospital Baptist Cardiac & Vascular Institute
More informationIn Situ Breast Carcinoma. James L. Connolly, M.D Beth Israel Deaconess Medical Center Professor of Pathology Harvard Medical School Boston, MA
In Situ Breast Carcinoma James L. Connolly, M.D Beth Israel Deaconess Medical Center Professor of Pathology Harvard Medical School Boston, MA Content In Situ Ductal Carcinoma In Situ Lobular Carcinoma
More informationTata Memorial Centre s opinion is summarized as follows:
February 2 nd 2015 Dear Ms., Thank you for reaching out to Tata Memorial Centre for an expert opinion in regard to assessing your treatment options. Navya Network is pleased to offer this online consultation
More informationLobular Carcinoma In Situ Variants in Breast Cores
Lobular Carcinoma In Situ Variants in Breast Cores Potential for Misdiagnosis, Upgrade Rates at Surgical Excision, and Practical Implications Megan E. Sullivan, MD; Seema A. Khan, MD; Yurdanur Sullu, MD;
More informationProliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease
Proliferative Breast Disease: implications of core biopsy diagnosis Jean F. Simpson, M.D. Breast Pathology Consultants, Inc. Nashville, TN Proliferative Breast Disease Must be interpreted in clinical and
More informationBreast cancer incidence. Multidisciplinary Management in Breast Cancer. Outline. The Breast 11/10/2014. Incidence of breast cancer in Thailand
Multidisciplinary Management in Breast Cancer October 8 th,2014 Ongart Somintara,M.D. Surgical Oncologist Department of Surgery, Khon Kaen University Breast cancer incidence USA : 2014 Estimate new case
More informationBreast Cancer. Dr. Andres Wiernik 2017
Breast Cancer Dr. Andres Wiernik 2017 Agenda: The Facts! (Epidemiology/Risk Factors) Biological Classification/Phenotypes of Breast Cancer Treatment approach Local Systemic Agenda: The Facts! (Epidemiology/Risk
More informationTreatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea
Treatment options for the precancerous Atypical Breast lesions Prof. YOUNG-JIN SUH The Catholic University of Korea Not so benign lesions? Imaging abnormalities(10% recall) lead to diagnostic evaluation,
More informationPapillary Lesions of the Breast
Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School
More informationBreast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina
Breast Imaging: Multidisciplinary Approach Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina No Disclosures Objectives Discuss a multidisciplinary breast
More informationBreastScreen Aotearoa Annual Report 2015
BreastScreen Aotearoa Annual Report 2015 EARLY AND LOCALLY ADVANCED BREAST CANCER PATIENTS DIAGNOSED IN NEW ZEALAND IN 2015 Prepared for Ministry of Health, New Zealand Version 1.0 Date November 2017 Prepared
More informationIBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina
Preoperative diagnosis and treatment planning in breast cancer The pathologist s perspective L. Mazzucchelli Istituto Cantonale di Patologia Locarno, Switzerland IBCM 2, 23-25 April 2009, Sarajevo, Bosnia
More informationA301 VI- Various cancer tissues with corresponding normal tissues
A301 VI- Various cancer tissues with (formalin fixed) For research use only Specifications: No. of cases: 28 Tissue type: Various cancer tissues with No. of spots: 2 spots from each cancer case (56 spots)
More informationSurgical Therapy: Sentinel Node Biopsy and Breast Conservation
Surgical Therapy: Sentinel Node Biopsy and Breast Conservation Stephen B. Edge, MD Professor of Surgery and Oncology Roswell Park Cancer Institute University at Buffalo Dr. Roswell Park: Tradition in Cancer
More informationBladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)
Bladder Case 1 February 17, 2007 Specimen (s) received: Bladder Tumor Pre-operative Diagnosis: Bladder Cancer Post operative Diagnosis: Bladder Cancer Procedure: Cystoscopy, transurethral resection of
More informationCompleting the Puzzle AJCC TNM Staging Breast. Nicole Catlett, CTR 2017 Kentucky Cancer Registry Fall Conference, September 21 & 22, 2017
Completing the Puzzle AJCC TNM Staging Breast Nicole Catlett, CTR 2017 Kentucky Cancer Registry Fall Conference, September 21 & 22, 2017 OBJECTIVES Understanding of Breast TNM staging Identify clinical
More informationCASE REPORT GASTRIC ADENOCARCINOMA METASTASIS TO THE BREAST- A DIFFERENTIAL DIAGNOSIS WITH PRIMARY BREAST ADENOCARCINOMA AND REVIEW OF LITERATURE.
GASTRIC ADENOCARCINOMA METASTASIS TO THE BREAST- A DIFFERENTIAL DIAGNOSIS WITH PRIMARY BREAST ADENOCARCINOMA AND REVIEW OF LITERATURE. Ashwin Hebbar.K 1, Shashidar. K 2, Kamal Kishor 3, Manjunath 4, Shivakumar.H.
More informationA DEEPER DIVE INTO DUCTAL CARCINOMA IN SITU: CLINICAL AND PATHOLOGIC CONSIDERATIONS IN 2015
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 A DEEPER DIVE INTO DUCTAL CARCINOMA IN SITU: CLINICAL AND PATHOLOGIC CONSIDERATIONS IN 2015
More informationDiseases of the breast (2 of 2) Breast cancer
Diseases of the breast (2 of 2) Breast cancer Epidemiology & etiology The most common type of cancer & the 2 nd most common cause of cancer death in women 1 of 8 women in USA Affects 7% of women Peak at
More informationDecember 2002 Monthly Memo
FLORIDA CANCER DATA SYSTEM December 2002 Monthly Memo CODING COMPLEX MORPHOLOGIC DIAGNOSES CODING COMPLEX BREAST HISTOLOGIES Apply these guidelines in priority order. Use the first guideline that applies
More informationToru Nakamura 1, Takashi Fukutomi 1, Hitoshi Tsuda 2, Sadako Akashi-Tanaka 1, Kaneyuki Matsuo 1, Chikako Shimizu 1 and Kunihisa Miyakawa 3
Jpn J Clin Oncol 2000;30(10)453 457 Changes in Findings of Mammography, Ultrasonography and Contrast-enhanced Computed Tomography of Three Histological Complete Responders with Primary Breast Cancer Before
More informationA201(VI)- Various cancer tissues
A201(VI)- Various cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 44 Tissue type: Various cancer tissues No. of spots: 2 spots from each cancer case (88 spots) Total
More informationMaram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine
Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine The most common non-skin malignancy of women 2 nd most common cause of cancer deaths in women, following
More informationNeuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters
& 2004 USCAP, Inc All rights reserved 0893-3952/04 $25.00 www.modernpathology.org Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical
More informationJournal of Breast Cancer
CSE REPORT Journal of reast Cancer J reast Cancer 2016 December; 19(4): 459-464 Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in dvanced reast Cancer Gi Won Shin, Young Mi Park,
More informationTOTALS 30. Preliminary analysis of NNDEQA 004 (May 2013 TSL workshops) 1) 70 year old female with focal irregularity in the right breast.
-- Preliminary analysis of NNDEQA 00 (May 0 TSL workshops) ) 70 year old female with focal irregularity in the right breast. Fat necrosis (with organising thrombus/foreign body granuloma/surgical site
More informationWhat is the recommended regimen for adjuvant radiation therapy? Tata Memorial Centre s opinion is summarized as follows:
February 3 rd 2015 Dear Ms., Thank you for reaching out to Tata Memorial Centre for an expert opinion in regard to assessing your treatment options. Navya Network is pleased to offer this online consultation
More information